United States · 
What does Altitude Life Science Ventures invest in?
Altitude Life Science Ventures invests most often at Series B and Series C (64% of the rounds on record), in sectors such as Venture Capital & Private Equity.
Altitude Life Science Ventures highlights
- 01
11 rounds on record
- 02
Mostly Series B and Series C: 64% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Venture Capital & Private Equity
- Based in
- New York, United States
- Cold pitches
- Not stated
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first11 appearances
- 2012
1 round
- Jul
- 2011
3 rounds
- Sept
- Sept
- Jun
- 2010
1 round
- Oct
- 2009
3 rounds
- Nov
- Aug
- Jul
- 2008
2 rounds
- Jun
- May
- 2006
1 round
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Kythera BiopharmaceuticalsBought by Allergan$2.1BJun 2015
An exit counts when it came after the firm's first round in the company. From historical deal records.